John Schoellerman
Chief Investment Officer presso OXFORD NANOPORE TECHNOLOGIES PLC
Profilo
John Schoellerman is currently the Chairman at Eagle Genomics Ltd.
and the SVP-Corporate Development & Investment at Oxford Nanopore Technologies Plc.
He was previously the Managing Director & Head-Medtech at Lazard Services Holdings Ltd.
He completed his undergraduate degree at Harvard University and earned an MBA from INSEAD.
Posizioni attive di John Schoellerman
Società | Posizione | Inizio |
---|---|---|
OXFORD NANOPORE TECHNOLOGIES PLC | Chief Investment Officer | 01/01/2019 |
Eagle Genomics Ltd.
Eagle Genomics Ltd. Packaged SoftwareTechnology Services Eagle Genomics Ltd. provides bioinformatics software and services. The firm products include eaglecore and eaglensembl. Its services include NGS data management, analysis, and visualization, and cloud computing for bioinformatics, biomarker discovery, microarray analysis, reproducing methods, and custom software development. The company was founded by Abel Ureta-Vidal in 2008 and is headquartered in Cambridge, the United Kingdom. | Chairman | 29/09/2023 |
Precedenti posizioni note di John Schoellerman
Società | Posizione | Fine |
---|---|---|
Lazard Services Holdings Ltd. | Corporate Officer/Principal | - |
Formazione di John Schoellerman
Harvard University | Undergraduate Degree |
INSEAD | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
OXFORD NANOPORE TECHNOLOGIES PLC | Electronic Technology |
Aziende private | 2 |
---|---|
Lazard Services Holdings Ltd. | |
Eagle Genomics Ltd.
Eagle Genomics Ltd. Packaged SoftwareTechnology Services Eagle Genomics Ltd. provides bioinformatics software and services. The firm products include eaglecore and eaglensembl. Its services include NGS data management, analysis, and visualization, and cloud computing for bioinformatics, biomarker discovery, microarray analysis, reproducing methods, and custom software development. The company was founded by Abel Ureta-Vidal in 2008 and is headquartered in Cambridge, the United Kingdom. | Technology Services |
- Borsa valori
- Insiders
- John Schoellerman